ZICCUM AB releases Annual Report for 2020

  • by ziccum-admin

    • (Lund, Sweden, 23 March 2021) Ziccum AB today announces that its Annual Report for 2020 is now available on the company’s website.

    For further information and to read the Full Report (in Swedish) please visit:: 
    https://ziccum.com/investors/financial-reports/

    The above information above was provided by Ziccum AB (publ) through the above contact person, for publication at 0815 on March 23, 2021.

    For more information about Ziccum, please contact:

    Göran Conradson: CEO Ziccum AB
    Mail: conradson@ziccum.com
    Mobile: +46 709 61 55 99
     
    Certified Adviser
    Erik Penser Bank AB
    Mail: certifiedadviser@penser.se
    Phone: +46 8 463 83 00

    About Ziccum

    Ziccum develops new thermostable versions of the world's most urgently needed, life-saving vaccines. The Company's patented technology, LaminarPace, enables the production of new, gently air-dried formulations that can be transported easily and cost-effectively, with no need for a costly and complicated cold chain, all the way from the factory to the last child in the last mile of the supply chain.

    Attachments

    Årsredovisning 2020 Final

    Årsredovisning 2020 Final